Asymmetric Synthesis of a DPP-4 Inhibitor
Significance: The target tetrahydropyran DPP-4 inhibitor was of interest for the treatment of type 2 diabetes. The synthesis depicted features three tandem ruthenium-catalyzed reactions: (1) an asymmetric transfer hydrogenation of ketone A with dynamic kinetic resolution (2) a cycloisomerization to form a dihydropyran ring and (3) an oxidation. The overall yield of the synthesis is 25%.
Comment: Extensive optimization of the asymmetric transfer hydrogenation established that significant contributors to the yield, dr and er included the use of the pentafluoro-substituted DAIPEN catalyst B, DABCO as the base and THF as the solvent. The reductive amination of ketone I with NaBH(OAc) 3 dramatically improved (dr = 19:1) using DMAc as solvent when the bis(tosylate) salt J was neutralized with Et 3 N followed by pH buffering with HOAc. 
